Stoke Therapeutics, Inc.
| CIK |
Ticker |
Name |
Accession Number |
Date |
Form |
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-25-089188 |
2025-04-22 16:05:27 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001104659-24-118991 |
2024-11-14 16:24:49 |
SC 13G
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001086364-24-008222 |
2024-07-08 16:32:41 |
SC 13G
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-24-106979 |
2024-04-23 16:06:27 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0000902664-23-005344 |
2023-11-06 16:55:23 |
SC 13G
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-23-245609 |
2023-09-28 16:05:26 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-23-122085 |
2023-04-27 16:01:51 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0000895421-23-000192 |
2023-02-10 11:50:33 |
SC 13G
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-22-120199 |
2022-04-26 16:02:01 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001104659-22-018638 |
2022-02-10 08:37:55 |
SC 13G
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001085146-22-000291 |
2022-01-24 07:44:58 |
SC 13G
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001123292-21-001063 |
2021-06-30 16:19:42 |
SC 13D
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-21-131444 |
2021-04-26 16:02:01 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001104659-21-023948 |
2021-02-16 16:09:01 |
SC 13G
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0000315066-21-001297 |
2021-02-08 10:33:49 |
SC 13G
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-20-113542 |
2020-04-21 16:16:04 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001104659-20-021017 |
2020-02-14 10:20:19 |
SC 13G
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0000929638-19-000658 |
2019-07-01 16:10:22 |
SC 13G
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-19-186323 |
2019-06-28 20:23:33 |
SC 13D
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001493152-19-009851 |
2019-06-28 10:19:11 |
SC 13G
|
